ANL 10.28 Decreased By ▼ -0.05 (-0.48%)
ASC 9.09 Increased By ▲ 0.02 (0.22%)
ASL 10.99 Decreased By ▼ -0.21 (-1.88%)
AVN 77.60 Decreased By ▼ -0.78 (-1%)
BOP 5.40 Decreased By ▼ -0.03 (-0.55%)
CNERGY 5.33 Decreased By ▼ -0.04 (-0.74%)
FFL 6.60 Decreased By ▼ -0.03 (-0.45%)
FNEL 5.85 Decreased By ▼ -0.10 (-1.68%)
GGGL 11.09 Increased By ▲ 0.03 (0.27%)
GGL 16.53 No Change ▼ 0.00 (0%)
GTECH 8.41 No Change ▼ 0.00 (0%)
HUMNL 7.14 Decreased By ▼ -0.02 (-0.28%)
KEL 3.00 Decreased By ▼ -0.09 (-2.91%)
KOSM 3.21 Increased By ▲ 0.17 (5.59%)
MLCF 27.00 No Change ▼ 0.00 (0%)
PACE 3.00 No Change ▼ 0.00 (0%)
PIBTL 5.94 Decreased By ▼ -0.13 (-2.14%)
PRL 17.90 Decreased By ▼ -0.30 (-1.65%)
PTC 6.97 Decreased By ▼ -0.05 (-0.71%)
SILK 1.17 Increased By ▲ 0.01 (0.86%)
SNGP 34.28 Decreased By ▼ -0.13 (-0.38%)
TELE 10.81 Decreased By ▼ -0.22 (-1.99%)
TPL 9.08 Increased By ▲ 0.03 (0.33%)
TPLP 20.15 Increased By ▲ 0.11 (0.55%)
TREET 29.15 Decreased By ▼ -0.35 (-1.19%)
TRG 77.11 Increased By ▲ 0.06 (0.08%)
UNITY 20.05 Decreased By ▼ -0.19 (-0.94%)
WAVES 12.80 Increased By ▲ 0.10 (0.79%)
WTL 1.33 Decreased By ▼ -0.04 (-2.92%)
YOUW 4.99 Increased By ▲ 0.19 (3.96%)
BR100 4,101 Increased By 22 (0.54%)
BR30 15,026 Decreased By -95.4 (-0.63%)
KSE100 41,541 Increased By 243.1 (0.59%)
KSE30 15,805 Increased By 108.4 (0.69%)

Ursula von der Leyen

Swiss-EU deal: Live or let die?
Business & Finance

Swiss-EU deal: Live or let die?

  • But ahead of Swiss President Guy Parmelin's meeting with European Commission president Ursula von der Leyen, Bern has kept its cards close to its chest on what approach it plans to take.
Published 23 Apr, 2021 11:12am
EU unveils AI rules to temper Big Brother fears
World

EU unveils AI rules to temper Big Brother fears

  • The bloc is trying to learn the lessons after largely missing out on the internet revolution and failing to produce any major competitors to match the giants of Silicon Valley or their Chinese counterparts.
Published 21 Apr, 2021 11:29am
EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2
World

EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2

  • Ursula von der Leyen said the earlier deliveries, which will start this month, will take total supplies to the EU from Pfizer to 250 million doses in the second quarter of this year.
  • She also confirmed the Commission was in talks with the two companies for a new contract for 1.8 billion doses to be delivered in 2022 and 2023, confirming a Reuters report last week.
Published 14 Apr, 2021 05:32pm
EU presidents to go to Turkey next week, spokesman says
World

EU presidents to go to Turkey next week, spokesman says

  • Turkey, an EU candidate country, last held a formal summit with the two EU chiefs in March 2020, when Erdogan met Michel and von der Leyen in Ankara.
  • Both sides also aim to agree billions of euros in fresh EU support for Syrian refugees in Turkey.
Published 29 Mar, 2021 06:28pm
EU's von der Leyen considers visiting Turkey as ties defrost
World

EU's von der Leyen considers visiting Turkey as ties defrost

  • The EU threatened Ankara with sanctions last year after a flare-up in a decades-old dispute between Turkey and Greece over maritime jurisdiction and energy resources in the Mediterranean.
  • We underlined the importance of sustained de-escalation and of further strengthening confidence building to allow for a more positive EU-Turkey agenda.
Published 19 Mar, 2021 08:52pm
EU threatens tougher vaccine export curbs in dispute with UK, US
World

EU threatens tougher vaccine export curbs in dispute with UK, US

  • "If this situation does not change, we will have to reflect on how to make exports to vaccine-producing countries dependent on their level of openness," EU Commission President Ursula von der Leyen told a news conference.
  • "We are ready to use whatever tools we need to deliver on that," von der Leyen said.
Published 17 Mar, 2021 05:42pm
EU approves Johnson & Johnson Covid vaccine
World

EU approves Johnson & Johnson Covid vaccine

  • The EU has so far approved three vaccines -- Pfizer-BioNTech, Moderna and AstraZeneca-Oxford. Three other vaccines are under "rolling review" by the Amsterdam-based EMA -- Novavax, CureVac and Russia's Sputnik.
Published 12 Mar, 2021 10:12am